Courier Therapeutics
Biotechnology Research
Houston, Texas, United States
6 employees
- Employees
- 6
Courier Therapeutics Overview
- Headquarters
- Houston, Texas, United States
- Website
- couriertherapeutics.com
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2015
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Courier Therapeutics
Courier Therapeutics is a biotechnology startup with a cytotoxic-lymphocyte targeting therapy platform, with a focus on making cancer-immunotherapy safer and more efficacious. Courier's first application of this targeting technology technology, CT101, is a first-in-class IL2R agonist which specifically activates the NK and CD8 T cells against cancer.
Courier Therapeutics Contact Details
Compare Similar Companies to Courier Therapeutics
Be Biopharma
Biotechnology
Alpha-9 Oncology
Biotechnology Research
Texas Medical Center Innovation Factory
Program Development
Mercury
Venture Capital And Private Equity Principals
Tentarix Biotherapeutics
Biotechnology
March Biosciences
Biotechnology
Secretome Therapeutics
Biotechnology Research
NKILT Therapeutics, Inc.
Biotechnology Research
BioLum Sciences
Biotechnology Research
Resonant Therapeutics
Biotechnology Research